Pharma Journalist -

CytoSen Therapeutics and KBI Biopharma announced a strategic partnership to manufacture therapeutic Natural Killer (NK) cells using a proprietary and scalable, closed system…
Read More...

SMi Reports: With just 4 weeks to go until the 8th Annual Orphan Drugs & Rare Diseases Conference, places for the conference and accompanying workshop on 16th October are becoming…
Read More...

Dr. Reddy’s Laboratories announced the closure of the sale of its antibiotic manufacturing facility and related assets in Bristol, Tennessee to Neopharma Inc., a wholly owned subsidiary…
Read More...

Dragonfly Therapeutics announced a strategic collaboration with Merck, known as MSD outside the United States and Canada, through a subsidiary, to discover, develop and commercialize…
Read More...

Vertex Pharmaceuticals (Europe) Limited announced it has entered into an innovative access contract with the Danish pharmaceutical and procurement organization, Amgros. Effective from…
Read More...

Exclusive Speaker Interview with Brent Cezairliyan for SMi’s Superbugs & Superdrugs USA SMi are delighted to have interviewed, speaker, Brent Cezairliyan, Senior Scientist,…
Read More...

15th November 2018, Kohinoor Continental Hotel, Mumbai, India Virtue Insight is glad to announce 17th Pharmacovigilance 2018 to be held on 15th November 2018 in Mumbai, India. It…
Read More...

Genentech announced that the U.S. Food and Drug Administration (FDA) has approved 75 mg/0.5 mL and 150 mg/1 mL single-dose prefilled syringes (PFS) for Xolair (omalizumab) as an…
Read More...

Innovent Biologics announced that its IND application for IBI-188, a fully human anti-CD47 monoclonal antibody (mAb) drug candidate, has been approved by the US Food & Drug…
Read More...

Enesi Pharma, an innovative pharmaceutical company developing unique injectable solid dose vaccine products, announces it has entered a Cooperative Research and Development Agreement…
Read More...